Brief: Ascelia Pharma Granted Chinese Patent For Second-Generation Orviglance
Dec 23 (Reuters) - Ascelia Pharma AB ACELP.ST :
* GRANTED CHINESE PATENT FOR SECOND-GENERATION ORVIGLANCE
* PATENT PROTECTION FOR ORVIGLANCE IN CHINA UNTIL 2040
Source text: ID:nMFN5M4CQ8
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))